Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Jun;54(6):1295-1302.
doi: 10.1007/s11255-021-03000-8. Epub 2021 Sep 28.

Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis

Wenyuan Gan  1 , Wenli Chen  1 , Tianyu Li  1 , Danni Shao  1 , Fang Xu  1 , Shanshan Huo  1 , Chenchen Li  1 , Zhenhua Yang  1 , Xingruo Zeng  2
Affiliations
Meta-Analysis

Circulating irisin level in chronic kidney disease patients: a systematic review and meta-analysis

Wenyuan Gan et al. Int Urol Nephrol. 2022 Jun.

Abstract

Background: Irisin is not only a myokine but also an adipokine that is critical in many diseases including in the development of such diseases as obesity, diabetes mellitus, metabolic syndrome, coronary artery disease, and chronic inflammation. However, the association between irisin and chronic kidney disease (CKD) is unclear. This systematic review aimed to assess circulating irisin levels in patients with CKD and compare them with those in non-CKD patients.

Methods: PubMed, EMBASE, CENTRAL, ISI Web of Science, and CNKI were searched to identify observational studies of circulating irisin levels in patients with CKD. Two reviewers independently searched the databases and screened studies according to the inclusion criteria. Data were extracted using a standardized collection form. Meta-analysis was performed to compare the differences in circulating irisin levels between CKD and non-CKD patients.

Results: A total of 9 studies (6 cross-sectional and 3 case controls) involving 859 CKD patients and 393 non-CKD individuals were selected. The pooled data indicated that circulating irisin concentrations were significantly lower in CKD nondialysis patients (WMD = - 84.79, 95% CI - 170.23, 0.50; p < 0.05), peritoneal dialysis patients (WMD = - 235.81, 95% CI - 421.99, - 49.62; p = 0.01), and hemodialysis patients (WMD = - 217.46, 95% CI - 381.35, - 53.57; p = 0.009) than in healthy controls.

Conclusions: This study confirmed that irisin levels were decreased in patients with CKD. Moreover, circulating irisin levels were lower in dialysis patients than in nondialysis patients.

Keywords: Chronic kidney disease; Dialysis; Irisin; Meta-analysis.

PubMed Disclaimer

References

    1. Conley MM, McFarlane CM, Johnson DW et al (2021) Interventions for weight loss in people with chronic kidney disease who are overweight or obese. Cochrane Database Syst Rev 3:Cd013119 - PubMed
    1. Bakker EA, Zoccali C, Dekker FW et al (2021) Assessing physical activity and function in patients with chronic kidney disease: a narrative review. Clin Kidney J 14:768–779 - DOI
    1. Matsuzawa R, Matsunaga A, Wang G et al (2012) Habitual physical activity measured by accelerometer and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 7:2010–2016 - DOI
    1. Zhong X, Sun X, Shan M et al (2021) The production, detection, and origin of irisin and its effect on bone cells. Int J Biol Macromol 178:316–324 - DOI
    1. Boström P, Wu J, Jedrychowski MP et al (2012) A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468 - DOI

LinkOut - more resources